BCS1L and pancreatic neoplasm: Taken together, our data indicate that recombinant PTD-RBD-VIF interacts with mutant KRAS and induces its ubiquitination and degradation, thereby inhibiting the growth of pancreatic cancer cells in vitro and in vivo.